2020 Scientific Sessions

Polyvascular Disease, Secondary Prevention in PVI Patients With PVD

Sponsored by SCAI. Supported by Janssen.
Antithrombotic Agents for Patients With Polyvascular Disease and After Peripheral Vascular Intervention
Marc P. Bonaca, MD, MPH, University of Colorado School of Medicine, Aurora, CO
PSCK9 Inhibitors for Patients With Polyvascular Disease
Dharam J. Kumbhani, M.D., FSCAI, The University of Texas Southwestern Medical Center, Dallas, TX
Combined Treatment of Coronary and Peripheral Artery Disease: Case Examples
Sahil A. Parikh, MD, FSCAI, NewYork-Presbyterian Columbia University Irving Medical Center, New York, NY
See more of: Satellite Sessions